000			02097 a2200589 4500
005			20250517030418.0
264		0	_c20160411
008			201604s 0 0 eng d
022			_a1536-4828
024	7		_a10.1097/MPA.0000000000000348 _2doi
040			_aNLM _beng _cNLM
100	1		_aKawabata, Yasunari
245	0	0	_aPrognostic Value of Excision Repair Cross-Complementing Gene 1, Dihydropyrimidine Dehydrogenase, and Human Equilibrative Nucleotide Transporter 1 Expression and Their Implications for Adjuvant Treatment in Patients With Ampullary Carcinoma. _h[electronic resource]
260			_bPancreas _cAug 2015
300			_a937-44 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAmpulla of Vater _xenzymology
650	0	4	_aBiomarkers, Tumor _xanalysis
650	0	4	_aCarcinoma _xenzymology
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aChi-Square Distribution
650	0	4	_aCommon Bile Duct Neoplasms _xenzymology
650	0	4	_aDNA-Binding Proteins _xanalysis
650	0	4	_aDihydrouracil Dehydrogenase (NADP) _xanalysis
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aEndonucleases _xanalysis
650	0	4	_aEquilibrative Nucleoside Transporter 1 _xanalysis
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aNeoplasm Recurrence, Local
650	0	4	_aPancreaticoduodenectomy _xadverse effects
650	0	4	_aPatient Selection
650	0	4	_aProportional Hazards Models
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aNishi, Takeshi
700	1		_aKidani, Akihiko
700	1		_aTajima, Yoshitsugu
773	0		_tPancreas _gvol. 44 _gno. 6 _gp. 937-44
856	4	0	_uhttps://doi.org/10.1097/MPA.0000000000000348 _zAvailable from publisher's website
999			_c24835979 _d24835979